113 related articles for article (PubMed ID: 11458338)
1. Formulation and characterization of amphotericin B-polyethylenimine-dextran sulfate nanoparticles.
Tiyaboonchai W; Woiszwillo J; Middaugh CR
J Pharm Sci; 2001 Jul; 90(7):902-14. PubMed ID: 11458338
[TBL] [Abstract][Full Text] [Related]
2. Insulin containing polyethylenimine-dextran sulfate nanoparticles.
Tiyaboonchai W; Woiszwillo J; Sims RC; Middaugh CR
Int J Pharm; 2003 Apr; 255(1-2):139-51. PubMed ID: 12672610
[TBL] [Abstract][Full Text] [Related]
3. Formulation and characterization of amphotericin B-chitosan-dextran sulfate nanoparticles.
Tiyaboonchai W; Limpeanchob N
Int J Pharm; 2007 Feb; 329(1-2):142-9. PubMed ID: 17000065
[TBL] [Abstract][Full Text] [Related]
4. Mucoadhesive polyethylenimine-dextran sulfate nanoparticles containing Punica granatum peel extract as a novel sustained-release antimicrobial.
Tiyaboonchai W; Rodleang I; Ounaroon A
Pharm Dev Technol; 2015 Jun; 20(4):426-32. PubMed ID: 24438035
[TBL] [Abstract][Full Text] [Related]
5. Formulation and characterization of DNA-polyethylenimine-dextran sulfate nanoparticles.
Tiyaboonchai W; Woiszwillo J; Middaugh CR
Eur J Pharm Sci; 2003 Jul; 19(4):191-202. PubMed ID: 12885383
[TBL] [Abstract][Full Text] [Related]
6. Formulation and optimization of nanoemulsion using antifungal lipid and surfactant for accentuated topical delivery of Amphotericin B.
Hussain A; Singh VK; Singh OP; Shafaat K; Kumar S; Ahmad FJ
Drug Deliv; 2016 Oct; 23(8):3101-3110. PubMed ID: 27854145
[TBL] [Abstract][Full Text] [Related]
7. Mucoadhesive chitosan-dextran sulfate nanoparticles for sustained drug delivery to the ocular surface.
Chaiyasan W; Srinivas SP; Tiyaboonchai W
J Ocul Pharmacol Ther; 2013 Mar; 29(2):200-7. PubMed ID: 23356788
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and evaluation of sodium deoxycholate sulfate as a lipid drug carrier to enhance the solubility, stability and safety of an amphotericin B inhalation formulation.
Gangadhar KN; Adhikari K; Srichana T
Int J Pharm; 2014 Aug; 471(1-2):430-8. PubMed ID: 24907597
[TBL] [Abstract][Full Text] [Related]
9. Gelatin coated hybrid lipid nanoparticles for oral delivery of amphotericin B.
Jain S; Valvi PU; Swarnakar NK; Thanki K
Mol Pharm; 2012 Sep; 9(9):2542-53. PubMed ID: 22845020
[TBL] [Abstract][Full Text] [Related]
10. Preparation, characterization, and evaluation of amphotericin B-loaded MPEG-PCL-g-PEI micelles for local treatment of oral
Zhou L; Zhang P; Chen Z; Cai S; Jing T; Fan H; Mo F; Zhang J; Lin R
Int J Nanomedicine; 2017; 12():4269-4283. PubMed ID: 28652732
[TBL] [Abstract][Full Text] [Related]
11. Designing chitosan-dextran sulfate nanoparticles using charge ratios.
Chen Y; Mohanraj VJ; Wang F; Benson HA
AAPS PharmSciTech; 2007 Nov; 8(4):E98. PubMed ID: 18181558
[TBL] [Abstract][Full Text] [Related]
12. Nanocapsules of Sterculia striata acetylated polysaccharide as a potential monomeric amphotericin B delivery matrix.
Matoso Sombra F; Richter AR; de Araújo AR; de Oliveira Silva Ribeiro F; de Fátima Souza Mendes J; Dos Santos Fontenelle RO; da Silva DA; Beserra de Paula HC; Pessoa de Andrade Feitosa J; Martín Goycoolea F; Monteiro de Paula RC
Int J Biol Macromol; 2019 Jun; 130():655-663. PubMed ID: 30797806
[TBL] [Abstract][Full Text] [Related]
13. Assessment of in vitro antifungal efficacy and in vivo toxicity of Amphotericin B-loaded PLGA and PLGA-PEG blend nanoparticles.
Moraes Moreira Carraro TC; Altmeyer C; Maissar Khalil N; Mara Mainardes R
J Mycol Med; 2017 Dec; 27(4):519-529. PubMed ID: 28797532
[TBL] [Abstract][Full Text] [Related]
14. Enhanced immune response against pertussis toxoid by IgA-loaded chitosan-dextran sulfate nanoparticles.
Sharma S; Mukkur TK; Benson HA; Chen Y
J Pharm Sci; 2012 Jan; 101(1):233-44. PubMed ID: 21953499
[TBL] [Abstract][Full Text] [Related]
15. Preparation and In vitro Evaluation of Efficacy and Toxicity of Polysorbate 80-coated Bovine Serum Albumin Nanoparticles containing Amphotericin B.
Pedroso LS; Khalil NM; Mainardes RM
Curr Drug Deliv; 2018; 15(7):1055-1063. PubMed ID: 29629661
[TBL] [Abstract][Full Text] [Related]
16. Nanoemulsion gel-based topical delivery of an antifungal drug: in vitro activity and in vivo evaluation.
Hussain A; Samad A; Singh SK; Ahsan MN; Haque MW; Faruk A; Ahmed FJ
Drug Deliv; 2016; 23(2):642-47. PubMed ID: 25013957
[TBL] [Abstract][Full Text] [Related]
17. Method validation and nanoparticle characterization assays for an innovative amphothericin B formulation to reach increased stability and safety in infectious diseases.
Tadini MC; de Freitas Pinheiro AM; Carrão DB; Aguillera Forte ALS; Nikolaou S; de Oliveira ARM; Berretta AA; Marquele-Oliveira F
J Pharm Biomed Anal; 2017 Oct; 145():576-585. PubMed ID: 28777969
[TBL] [Abstract][Full Text] [Related]
18. Amphotericin B-loaded solid lipid nanoparticles (SLNs) and nanostructured lipid carrier (NLCs): effect of drug loading and biopharmaceutical characterizations.
Jansook P; Pichayakorn W; Ritthidej GC
Drug Dev Ind Pharm; 2018 Oct; 44(10):1693-1700. PubMed ID: 29936874
[TBL] [Abstract][Full Text] [Related]
19. Self-assembled amphotericin B-loaded polyglutamic acid nanoparticles: preparation, characterization and in vitro potential against Candida albicans.
Zia Q; Khan AA; Swaleha Z; Owais M
Int J Nanomedicine; 2015; 10():1769-90. PubMed ID: 25784804
[TBL] [Abstract][Full Text] [Related]
20. Amphotericin B-loaded polymeric nanoparticles: formulation optimization by factorial design.
Carraro TC; Khalil NM; Mainardes RM
Pharm Dev Technol; 2016 Mar; 21(2):140-6. PubMed ID: 25384838
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
